Carcinoma, Squamous Cell: all 1,779 studies
Page 8 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.
- Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00387335Phase 2Results posted
- Zalutumumab in Patients With Non-curable Head and Neck CancerCompletedNCT00382031Phase 3Results posted
- A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck CancerCompletedNCT00371566Phase 2Results posted
- A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell CarcinomaCompletedNCT00369512Phase 2Results posted
- Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical CancerCompletedNCT00369122Phase 2Results posted
- Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)CompletedNCT00343083Phase 2Results posted
- Post-Operative Drainage Following Lymph Node DissectionCompletedNCT00324272Phase 4Results posted
- Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the CervixCompletedNCT00285207Phase 2Results posted
- Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal CancerCompletedNCT00274937Phase 3Results posted
- Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or ChemoCompletedNCT00258310Phase 2Results posted
- IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT00229723Phase 2Results posted
- Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00184028Phase 2Results posted
- Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck CancerCompletedNCT00176254Phase 2Results posted
- Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin CancerCompletedNCT00126555Phase 2Results posted
- Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)CompletedNCT00122460Phase 3Results posted
- Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00103259Phase 2Results posted
- Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00096174Phase 2Results posted
- SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00095628Phase 2Results posted
- Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00084682Phase 2Results posted
- Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and NeckCompletedNCT00084318Phase 2Results posted
- Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the VulvaCompletedNCT00068406Phase 2Results posted
- ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the SkinCompletedNCT00054691Phase 2Results posted
- Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based TreatmentActive, not recruitingNCT07697287Phase 4
- A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.Active, not recruitingNCT07177638Not applicable
- Serum Lipid Profile and Lip Squamous Cell CarcinomaCompletedNCT07005115
- Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS SurgeryCompletedNCT06919809Not applicable
- Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell CarcinomaActive, not recruitingNCT06888531Phase 2
- A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT06879691Phase 4
- Functional Evaluation After Maxillectomy and Scapular Free Flap ReconstructionCompletedNCT06865313
- Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell CarcinomaCompletedNCT06854107
- The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）Active, not recruitingNCT06828718
- Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical CarcinomaCompletedNCT06781073Phase 3
- Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCCCompletedNCT06775652Phase 3
- Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the CervixActive, not recruitingNCT06771596Phase 2
- Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCCWithdrawnNCT06762808Phase 2
- NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCCActive, not recruitingNCT06762158Not applicable
- ctDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)CompletedNCT06730412
- A Clinical Trial of Esophagectomy for Esophageal CarcinomaCompletedNCT06691503Phase 2
- Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell CarcinomaWithdrawnNCT06644079Phase 2
- Multi-Site Pathological Images-Guided ViT for Oral Squamous Cell Carcinoma Recurrence PredictionCompletedNCT06638762
- Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell CarcinomaCompletedNCT06606301
- Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal TherapyCompletedNCT06556355
- A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal CancerWithdrawnNCT06513884Phase 2/3
- Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）Active, not recruitingNCT06478355Not applicable
- a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC StudyActive, not recruitingNCT06472635
- PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STSCompletedNCT06413095Early Phase 1
- Changhai Multimodal Esophageal Cancer CohortActive, not recruitingNCT06410677
- Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)WithdrawnNCT06384820Phase 2
- 10-year Retrospective Study of Oral and Maxillofacial Squamous Cell CarcinomaCompletedNCT06366906
- Exploring the Optimal Timing of Minimally Invasive Surgery for Esophageal Squamous Cell CarcinomaCompletedNCT06364566Not applicable
- ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT06357858Phase 1
- Association Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patients With Cervical HSILCompletedNCT06325592
- Ex Vivo 3D-ultrasound for Oropharyngeal CancerCompletedNCT06314711Not applicable
- A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)TerminatedNCT06295809Phase 2/3
- Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.CompletedNCT06259838
- Machine Learning to Predict Lymph Node Metastasis in T1 Esophageal Squamous Cell CarcinomaCompletedNCT06256185Not applicable
- Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT06241079
- The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell CarcinomaCompletedNCT06241066
- TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCCCompletedNCT06236425Phase 1
- Skin Tumor Biomarkers by Mass Spectrometry ImagingActive, not recruitingNCT06227416Not applicable
- Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.CompletedNCT06190652
- HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell CarcinomaCompletedNCT06184841Phase 1
- Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Overall Survival of Patients With Thoracic Esophageal Squamous Cell Carcinoma: An Observational StudyCompletedNCT06165094
- Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)CompletedNCT06159842Phase 2
- Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic SurgeryCompletedNCT06112535Not applicable
- Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral MucosaCompletedNCT06094829
- PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCCCompletedNCT06062602Early Phase 1
- Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant ChemoradiotherapyActive, not recruitingNCT06061263
- Study of ALE.C04 in Patients With Head and Neck CancerTerminatedNCT06054477Phase 1/2
- Needs and Preferences of Patients With Head-neck Cutaneous SCCActive, not recruitingNCT06046625
- A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)Active, not recruitingNCT06041802Phase 2
- Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell CarcinomaStatus unknownNCT06041464
- Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesTerminatedNCT06034860Phase 1
- Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy StudyCompletedNCT06031337
- Interobserver Variability DesmoplasiaCompletedNCT06020612
- Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)Active, not recruitingNCT06009861Phase 2
- Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the ScalpActive, not recruitingNCT05987579
- RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck CancerActive, not recruitingNCT05966194Phase 2
- Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCCActive, not recruitingNCT05951127Not applicable
- Identification of Oral Lesions Through an Autofluorescence SystemCompletedNCT05942794Not applicable
- Prognostic Immune Biomarkers in HNSCCCompletedNCT05941676
- Contribution of Residual Tumour DNA Testing on the Surgical BedActive, not recruitingNCT05934929Not applicable
- Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing RadiotherapyCompletedNCT05918224Phase 2
- Dose Optimized BNCT for Head and Neck CancerActive, not recruitingNCT05883007Phase 1
- Analyzing Clinical Outcomes and Genomic Data of American Indian Patient PopulationActive, not recruitingNCT05863052
- Liposomal Bupivacaine and Transoral Robotic SurgeryCompletedNCT05862792
- Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.Active, not recruitingNCT05858229Phase 1/2
- Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous CarcinomaStatus unknownNCT05854030
- Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell CarcinomaActive, not recruitingNCT05845632
- Artificial Intelligence Patient App for RDEB SCCsActive, not recruitingNCT05843994
- Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown PrimaryCompletedNCT05841966Not applicable
- Anal Intraepithelial Neoplasia and Anal Squamous Cell CarcinomaStatus unknownNCT05835960
- Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.Status unknownNCT05832593
- Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell CarcinomaCompletedNCT05821179
- A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsActive, not recruitingNCT05812027
- NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHNCompletedNCT05802290Phase 3
- Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT05784012Phase 1/2
- Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept StudyStatus unknownNCT05761132Phase 2
- A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell CarcinomaStatus unknownNCT05749042Phase 2
- Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHNWithdrawnNCT05743270Phase 2